GSC
IDXG

Ground Swell Capital’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Ground Swell Capital’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4
Closed -$2K – 2946
2014
Q2 		$2K Buy
+4
New +$1.85K ﹤0.01% 1582

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ground Swell Capital's IDXG Position: Q3 2014 in Review

Ground Swell Capital sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q3 2014, closing a stake of 4 shares — an estimated $2K sold.

Ground Swell Capital first reported a position in IDXG in Q2 2014 and held it in 1 quarter. The position peaked at $2K in Q2 2014. 27 funds tracked by Wall St. Rank hold IDXG as of Q3 2014.

  • Ground Swell Capital reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 4 Interpace Biosciences, Inc. Common Stock shares in Q3 2014, an estimated $2K.
  • Ground Swell Capital first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's Interpace Biosciences, Inc. Common Stock position peaked at $2K in Q2 2014.
  • 27 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.